Pituitary microadenomas. Does Gadolinium enhance their demonstration?

Area of Science:

• Radiology
• Endocrinology
• Neurosurgery

Background:

• Pituitary adenomas are common tumors affecting hormone regulation.
• Accurate imaging is crucial for diagnosis and surgical planning.

Purpose of the Study:

• To compare the efficacy of dynamic contrast-enhanced computed tomography (CT) and pre- and post-Gadolinium-DTPA enhanced magnetic resonance imaging (MRI) in detecting hormonally active pituitary adenomas.
• To evaluate the added value of Gadolinium-DTPA enhanced MRI in visualizing microadenomas and their relationship to surrounding structures.

Main Methods:

• Ten patients with biochemical evidence of pituitary adenomas underwent dynamic contrast-enhanced CT.
• Subsequent pre- and post-Gadolinium-DTPA enhanced MRI scans were performed.
• Imaging findings were correlated with surgical outcomes.

Main Results:

• CT and unenhanced MRI showed comparable detection rates for microadenomas, excluding one false positive CT.
• Post-Gadolinium-DTPA MRI provided clearer evidence of adenomas in two patients and aided visualization in a third.
• Despite advanced imaging, microadenomas in two patients remained undetected and were only found during surgery.
• Post-enhancement MRI improved assessment of tumor relationships to the cavernous sinus and parasellar carotid arteries.

Conclusions:

• Gadolinium-DTPA enhanced MRI offers improved visualization of pituitary adenomas in select cases compared to CT and unenhanced MRI.
• Limitations in detecting all microadenomas persist, underscoring the need for multimodal diagnostic approaches.
• Enhanced MRI is valuable for delineating tumor-vascular relationships, aiding surgical planning.